Structure

InChI Key RTXOFQZKPXMALH-GHXIOONMSA-N
Smile C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\O)c3csc(N)n3)[C@H]2SC1
InChI
InChI=1S/C14H13N5O5S2/c1-2-5-3-25-12-8(11(21)19(12)9(5)13(22)23)17-10(20)7(18-24)6-4-26-14(15)16-6/h2,4,8,12,24H,1,3H2,(H2,15,16)(H,17,20)(H,22,23)/b18-7-/t8-,12-/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C14H13N5O5S2
Molecular Weight 395.42
AlogP -0.17
Hydrogen Bond Acceptor 9.0
Hydrogen Bond Donor 4.0
Number of Rotational Bond 5.0
Polar Surface Area 158.21
Molecular species ACID
Aromatic Rings 1.0
Heavy Atoms 26.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Bacterial penicillin-binding protein inhibitor PubMed PubMed DailyMed Wikipedia Wikipedia

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Bronchitis, Chronic 4 D029481 ClinicalTrials
Infections 4 D007239 ClinicalTrials
Mastitis 2 D008413 ClinicalTrials
Osteomyelitis 0 D010019 ClinicalTrials
Appendicitis 0 D001064 ClinicalTrials

Related Entries

MCS

Scaffolds

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Gastrointestinal disorders
18.97
General disorders and administration site conditions
15.53
Skin and subcutaneous tissue disorders
12.09
Immune system disorders
9.13
Nervous system disorders
6.34
Injury, poisoning and procedural complications
6.11
Psychiatric disorders
5.28
Respiratory, thoracic and mediastinal disorders
5.16
Infections and infestations
3.56
Cardiac disorders
2.96
Product issues
2.55
Musculoskeletal and connective tissue disorders
2.37
Vascular disorders
2.19

Cross References

Resources Reference
CAS NUMBER 91832-40-5
ChEBI 3485
ChEMBL CHEMBL927
DrugBank DB00535
DrugCentral 533
EPA CompTox DTXSID8046084
FDA SRS CI0FAO63WC
Human Metabolome Database HMDB0014675
KEGG C08110
PharmGKB PA164768739
PubChem 6915944
SureChEMBL SCHEMBL36995
ZINC ZINC000003927198